PYPD
PolyPid
NASDAQ: PYPD · HEALTHCARE · BIOTECHNOLOGY
$4.53
+2.26% today
Updated 2026-04-29
Market cap
$84.54M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.09
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
PolyPid (PYPD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.86M | $-2.52M | $-6.57M | $-9.73M | $-12.31M | $-16.68M | $-17.36M | $-21.60M | $-32.39M | $-34.32M | $-17.24M | $-21.96M | $-27.88M |
| Capital expenditures | $144999.00 | $48000.00 | $113000.00 | $539000.00 | $1.88M | $3.07M | $879000.00 | $1.18M | $2.99M | $1.77M | $196000.00 | $76000.00 | $210000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $373000.00 | — | $598000.00 | $1.38M | $995000.00 | $976000.00 | $4.58M | $4.75M | $4.31M | $3.39M | $2.82M | $4.85M |
| Free cash flow | $-2.00M | $-2.57M | $-6.69M | $-10.27M | $-14.20M | $-19.75M | $-18.24M | $-22.77M | $-35.38M | $-36.08M | $-17.43M | $-22.04M | $-28.09M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — |